Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer

NCT04134897 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

316

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasms Malignant
Rectum Carcinoma
Rectal Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Capecitabine
RADIATION: Radiotherapy
PROCEDURE: Rectal cancer surgery
RADIATION: Radiotherapy

Sponsor

Blokhin's Russian Cancer Research Center